These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28283844)

  • 1. Long term survival and cardiopulmonary outcome in children with Hurler syndrome after haematopoietic stem cell transplantation.
    Lum SH; Stepien KM; Ghosh A; Broomfield A; Church H; Mercer J; Jones S; Wynn R
    J Inherit Metab Dis; 2017 May; 40(3):455-460. PubMed ID: 28283844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome.
    Lum SH; Miller WP; Jones S; Poulton K; Ogden W; Lee H; Logan A; Bonney D; Lund TC; Orchard PJ; Wynn RF
    Bone Marrow Transplant; 2017 Jun; 52(6):846-853. PubMed ID: 28218755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
    Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
    Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term disease burden post-transplantation: three decades of observations in 25 Hurler patients successfully treated with hematopoietic stem cell transplantation (HSCT).
    Guffon N; Pettazzoni M; Pangaud N; Garin C; Lina-Granade G; Plault C; Mottolese C; Froissart R; Fouilhoux A
    Orphanet J Rare Dis; 2021 Jan; 16(1):60. PubMed ID: 33517895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome).
    Miebach E; Church H; Cooper A; Mercer J; Tylee K; Wynn RF; Wraith JE
    J Inherit Metab Dis; 2011 Jun; 34(3):755-61. PubMed ID: 21416193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
    Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
    Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres.
    Ghosh A; Miller W; Orchard PJ; Jones SA; Mercer J; Church HJ; Tylee K; Lund T; Bigger BW; Tolar J; Wynn RF
    Mol Genet Metab; 2016 Mar; 117(3):373-7. PubMed ID: 26832957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unrelated CD3/CD19-depleted peripheral stem cell transplantation for Hurler syndrome.
    Schwinger W; Sovinz P; Benesch M; Lackner H; Seidel M; Strenger V; Sperl D; Raicht A; Brunner-Krainz M; Paschke E; Plecko B; Urban C
    Pediatr Hematol Oncol; 2014 Nov; 31(8):723-30. PubMed ID: 25116402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of second hematopoietic cell transplantation in Hurler syndrome.
    Grewal SS; Krivit W; Defor TE; Shapiro EG; Orchard PJ; Abel SL; Lockman LA; Ziegler RS; Dusenbery KE; Peters C
    Bone Marrow Transplant; 2002 Mar; 29(6):491-6. PubMed ID: 11960268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome.
    Grewal SS; Wynn R; Abdenur JE; Burton BK; Gharib M; Haase C; Hayashi RJ; Shenoy S; Sillence D; Tiller GE; Dudek ME; van Royen-Kerkhof A; Wraith JE; Woodard P; Young GA; Wulffraat N; Whitley CB; Peters C
    Genet Med; 2005 Feb; 7(2):143-6. PubMed ID: 15714083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
    Uderzo C; Pillon M; Corti P; Tridello G; Tana F; Zintl F; Nysom K; Galambrun C; Fagioli F; Varotto S; Messina C; Verdeguer A; Urban C; Faraci M; Dini G; Fedeli S; Tichelli A; Rovelli A; Socié G
    Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources.
    Souillet G; Guffon N; Maire I; Pujol M; Taylor P; Sevin F; Bleyzac N; Mulier C; Durin A; Kebaili K; Galambrun C; Bertrand Y; Froissart R; Dorche C; Gebuhrer L; Garin C; Berard J; Guibaud P
    Bone Marrow Transplant; 2003 Jun; 31(12):1105-17. PubMed ID: 12796790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation.
    Schmidt M; Breyer S; Löbel U; Yarar S; Stücker R; Ullrich K; Müller I; Muschol N
    Orphanet J Rare Dis; 2016 Jul; 11(1):93. PubMed ID: 27392569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The evolution of pulmonary function in childhood onset Mucopolysaccharidosis type I.
    Broomfield A; Sims J; Mercer J; Hensman P; Ghosh A; Tylee K; Stepien KM; Oldham A; Prathivadi Bhayankaram N; Wynn R; Wright NB; Jones SA; Wilkinson S
    Mol Genet Metab; 2021 Feb; 132(2):94-99. PubMed ID: 32713717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstructive sleep apnea syndrome after hematopoietic stem cell transplantation in children with mucopolysaccharidosis type I.
    Moreau J; Brassier A; Amaddeo A; Neven B; Caillaud C; Chabli A; Fernandez-Bolanos M; Olmo J; Valayannopoulos V; Fauroux B
    Mol Genet Metab; 2015 Dec; 116(4):275-80. PubMed ID: 26602600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term adaptive functioning outcomes of children with inherited metabolic and genetic diseases treated with hematopoietic stem cell transplantation in a single large pediatric center: parents' perspective.
    Gassas A; Raiman J; White L; Schechter T; Clarke J; Doyle J
    J Pediatr Hematol Oncol; 2011 Apr; 33(3):216-20. PubMed ID: 21336168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth.
    Soncini E; Slatter MA; Jones LB; Hughes S; Hodges S; Flood TJ; Barge D; Spickett GP; Jackson GH; Collin MP; Abinun M; Cant AJ; Gennery AR
    Br J Haematol; 2009 Apr; 145(1):73-83. PubMed ID: 19222467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation.
    Bjoraker KJ; Delaney K; Peters C; Krivit W; Shapiro EG
    J Dev Behav Pediatr; 2006 Aug; 27(4):290-6. PubMed ID: 16906003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome.
    Cox-Brinkman J; Boelens JJ; Wraith JE; O'meara A; Veys P; Wijburg FA; Wulffraat N; Wynn RF
    Bone Marrow Transplant; 2006 Jul; 38(1):17-21. PubMed ID: 16715104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience.
    Rodgers NJ; Kaizer AM; Miller WP; Rudser KD; Orchard PJ; Braunlin EA
    J Inherit Metab Dis; 2017 Mar; 40(2):271-280. PubMed ID: 28054207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.